cancer screening Oct 19, 2022 Craig-Hallum Initiates Coverage of Guardant Health With Buy Rating Oct 19, 2022 Craig-Hallum Downgrades Exact Sciences to Hold, Lowers Price Target to $35 Oct 13, 2022 Consortium Studying Children, Families to Understand Pediatric Cancer Risk, Tumor Development Premium Sep 27, 2022 Optellum Raises $14M in Series A Financing Sep 6, 2022 Freenome Launches Multi-Cancer Detection Study Using Multiomics, Real-World Evidence Aug 8, 2022 VolitionRx Signs on Diagnostic Oncology CRO for Clinical Studies of Cancer, Sepsis Tests May 31, 2022 Grail, Veterans Affairs to Evaluate Galleri Cancer Early Detection Test May 16, 2022 Intermountain Healthcare Rolling Out Galleri Multi-Cancer Early Detection Test in Pilot Program Premium Apr 21, 2022 Consensus Builds for Real-World Evidence to Support Multi-Cancer Screening Tests Premium Apr 13, 2022 Guardant Health, Exact Sciences Make Progress on Multi-Cancer Detection Tests Premium Feb 15, 2022 Point32Health to Offer Grail Cancer Early Detection Test Under Pilot Program Feb 14, 2022 Mainz Biomed Partners with German Regional Lab on Colorectal Cancer Test Commercialization Feb 2, 2022 President Biden Jumpstarts Cancer Moonshot Initiative With Goal of Halving Death Rate Jan 19, 2022 Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Jan 7, 2022 Banner Year for Blood-Based Cancer Screening in 2021, but Reimbursement and Utility Hurdles Loom Premium Dec 14, 2021 Massive Bio Launches Plan to Enroll 100K Cancer Patients Into Clinical Trials Premium Aug 11, 2021 Sema4, Avera Health Collaborate on Precision Oncology Program Jun 4, 2021 Grail Launches Galleri Cancer Early Detection Test, Backed by First PATHFINDER Interventional Data Premium Apr 15, 2021 Grail Cancer Early Detection Test Performance Holds Steady as Q2 Launch Approaches Premium Mar 25, 2021 Genetron Health Updates Data from Prospective Liquid Biopsy Liver Cancer Screening Study Premium Load More Breaking News Ratio Therapeutics Raises $20M in Series A Financing Guardant Health, AnHeart Tx to Develop Blood- and Tissue-Based CDx for NSCLC Drug Ellipses Pharma Cleared by FDA to Open Phase I/II AML Trial Survey Reveals Changing Genetic Testing Patterns, Persistent Disparities in Precision Oncology Amgen's Lumakras Sales Increased 58 Percent in Q4 2022 Coeptis Therapeutics, University of Pittsburgh Studying SNAP-CAR Therapy in HER2-Positive Cancers
